A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies
Wh. Traub et al., A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies, CHEMOTHERA, 45(5), 1999, pp. 349-359
A multiple antibiotic-resistant (MAR) strain of Acinetobacter baumannii cau
sed nosocomial cross-infection among 3 patients of a surgical intensive car
e unit. The isolates were of identical biochemical profile (77776 S-U-) and
serotype (serovar 36) and identical in terms of pulsed-field gel electroph
oresis macrorestriction (Smal, Apal) analysis. This MAR strain was suscepti
ble only to netilmicin, tobramycin, imipenem, meropenem, polymyxin B, and t
rovafloxacin. The minimal bactericidal concentrations of imipenem and merop
enem were markedly higher than the corresponding minimal inhibitory concent
rations against this strain. Combined fresh defibrinated human blood (65 vo
l%) and antimicrobial drug assays yielded the following results: polymyxin
was the most rapidly bactericidally effective antibiotic in the presence of
blood and in broth. Tobramycin and netilmicin were efficacious in 65 vol%
blood. Imipenem was slightly more effective than meropenem in broth, wherea
s both carbapenems sterilized blood-containing assay tube contents. Trovafl
oxacin failed to achieve bactericidal activity (to 99.9% kill) in the prese
nce of blood, presumably because this strain was resistant to ciprofloxacin
and borderline susceptible to ofloxacin. Trovafloxacin combined with eithe
r imipenem or meropenem yielded an indifferent effect. However, the combina
tion of trovafloxacin (2 mu g/ml) plus tobramycin(1 mu g/ml) achieved steri
lization of tube contents in the presence of blood within 4 h after exposur
e and in broth following extended (overnight) incubation. This MAR strain o
f A. baumannii was high-level resistant to rifampin; thus the combination o
f polymyxin B plus rifampin proved indifferent.